Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up
出版年份 2021 全文链接
标题
Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up
作者
关键词
COVID 19, Antiviral therapy, Medical risk factors, Fatigue, Interferons, Oxygen, Dyspnea, Virus testing
出版物
PLoS One
Volume 16, Issue 12, Pages e0260568
出版商
Public Library of Science (PLoS)
发表日期
2021-12-08
DOI
10.1371/journal.pone.0260568
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- Attributes and predictors of long COVID
- (2021) Carole H. Sudre et al. NATURE MEDICINE
- Sequelae in Adults at 6 Months After COVID-19 Infection
- (2021) Jennifer K. Logue et al. JAMA Network Open
- Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Post-acute COVID-19 syndrome
- (2021) Ani Nalbandian et al. NATURE MEDICINE
- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)
- (2020) Hiroshi Nishiura et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
- (2020) Yuhao Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Persistent Symptoms in Patients After Acute COVID-19
- (2020) Angelo Carfì et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Post‐discharge symptoms and rehabilitation needs in survivors of COVID‐19 infection: a cross‐sectional evaluation
- (2020) Stephen J Halpin et al. JOURNAL OF MEDICAL VIROLOGY
- Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)
- (2020) Shuofeng Yuan et al. Viruses-Basel
- Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020
- (2020) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study
- (2020) Qiutang Xiong et al. CLINICAL MICROBIOLOGY AND INFECTION
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients
- (2020) Hitoshi Kawasuji et al. PLoS One
- Immunogenetic Association Underlying Severe COVID-19
- (2020) Kendall McCoy et al. Vaccines
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Phillip D Monk et al. Lancet Respiratory Medicine
- Gender differences in autoimmune disease
- (2014) S.T. Ngo et al. FRONTIERS IN NEUROENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search